1,500 Shares in Aflac Incorporated (NYSE:AFL) Purchased by WFA of San Diego LLC

WFA of San Diego LLC purchased a new stake in Aflac Incorporated (NYSE:AFLFree Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,500 shares of the financial services provider’s stock, valued at approximately $105,000.

A number of other hedge funds also recently modified their holdings of the stock. Bank Julius Baer & Co. Ltd Zurich grew its holdings in Aflac by 99,608.4% in the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,691,395,636 shares of the financial services provider’s stock worth $118,059,415,000 after purchasing an additional 1,689,699,293 shares during the period. Envestnet Asset Management Inc. lifted its position in shares of Aflac by 338.0% during the first quarter. Envestnet Asset Management Inc. now owns 5,604,901 shares of the financial services provider’s stock valued at $93,656,000 after purchasing an additional 4,325,212 shares in the last quarter. First Trust Advisors LP boosted its holdings in Aflac by 71.2% during the first quarter. First Trust Advisors LP now owns 6,512,084 shares of the financial services provider’s stock worth $420,160,000 after purchasing an additional 2,707,608 shares during the last quarter. Norges Bank bought a new stake in Aflac in the 4th quarter worth about $175,416,000. Finally, Invesco Ltd. increased its stake in Aflac by 62.4% in the 1st quarter. Invesco Ltd. now owns 4,936,608 shares of the financial services provider’s stock valued at $317,865,000 after buying an additional 1,897,212 shares during the last quarter. Institutional investors own 66.75% of the company’s stock.

Insider Activity at Aflac

In related news, Director William P. Bowers sold 23,701 shares of Aflac stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $81.51, for a total value of $1,931,868.51. Following the transaction, the director now directly owns 60,118 shares of the company’s stock, valued at $4,900,218.18. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Joseph L. Moskowitz sold 500 shares of the business’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $76.47, for a total transaction of $38,235.00. Following the completion of the sale, the director now owns 26,598 shares of the company’s stock, valued at approximately $2,033,949.06. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director William P. Bowers sold 23,701 shares of Aflac stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $81.51, for a total transaction of $1,931,868.51. Following the transaction, the director now owns 60,118 shares in the company, valued at approximately $4,900,218.18. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 162,201 shares of company stock valued at $13,163,404. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. StockNews.com initiated coverage on Aflac in a research report on Thursday, October 5th. They set a “hold” rating for the company. Raymond James raised their target price on Aflac from $77.00 to $83.00 and gave the company an “outperform” rating in a research report on Tuesday, September 26th. Jefferies Financial Group increased their price target on shares of Aflac from $70.00 to $74.00 and gave the company a “hold” rating in a research report on Thursday, September 14th. Citigroup lifted their price objective on shares of Aflac from $69.00 to $76.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 9th. Finally, JPMorgan Chase & Co. increased their target price on shares of Aflac from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, November 2nd. Seven research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $79.63.

View Our Latest Report on Aflac

Aflac Trading Down 0.7 %

Shares of AFL opened at $81.17 on Tuesday. Aflac Incorporated has a 1-year low of $60.20 and a 1-year high of $82.71. The company has a market capitalization of $47.43 billion, a P/E ratio of 10.69, a P/E/G ratio of 1.97 and a beta of 0.89. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.08 and a quick ratio of 0.08. The firm’s 50 day simple moving average is $78.65 and its 200 day simple moving average is $73.47.

Aflac (NYSE:AFLGet Free Report) last posted its quarterly earnings data on Thursday, November 2nd. The financial services provider reported $1.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.44 by $0.40. The firm had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.31 billion. Aflac had a return on equity of 17.86% and a net margin of 24.17%. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period in the prior year, the business earned $1.23 EPS. Sell-side analysts forecast that Aflac Incorporated will post 6.26 earnings per share for the current fiscal year.

Aflac Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Wednesday, November 15th will be paid a $0.42 dividend. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.07%. Aflac’s dividend payout ratio (DPR) is 26.35%.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Further Reading

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.